Statistics
Publications
3
Citations
98
H-Index
3
Active since
2019
Clemens Dobelmann is an author at National Institutes of Health specializing in cancer pharmacology, pyrimidine analogues, and enzyme inhibition.
Publications per year
2019–2022
3
3
Paola Oliva, Mirko Scortichini, Clemens Dobelmann et al. · Bioorganic & Medicinal Chemistry Letters · 2021 · 11 citations · Full text
1–3 of 3